Arch Biopartners
Toronto
About Arch Biopartners
Arch Biopartners Inc., a biotechnology company, focuses on acquiring and developing products and technology for sale to pharmaceutical and industrial companies. The company, through its subsidiaries, focuses on developing diagnosis and treatments for brain tumors; binding of peptides to solid surfaces; treatments for chronic kidney and bowel diseases caused by non-infectious inflammation; and anti-cancer compounds. Arch Biopartners Inc. is headquartered in Toronto, Canada.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $6.5M
- Funding stage: IPO
- Last round: Post-IPO Equity (Nov 2025)
- Ticker: otcpink:ACHFF
- Website: archbiopartners.com
- Phone: (647) 428–7031
Industries & Categories
Biopharma, Biotechnology, Medical
Social Profiles
Canonical: https://fsome.com/organization/arch-biopartners-119516 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.